Inhibition of sodium‐glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis‐related kidney disease

The effect of sodium‐glucose cotransporter 2 inhibitor (SGLT2I) on nonalcoholic steatohepatitis (NASH) has been reported, but there are few studies on its effect on NASH‐related renal injury. In this study, we examined the effect of SGLT2I using a novel medaka fish model of NASH‐related kidney disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagoya, Takuro, Kamimura, Kenya, Goto, Ryo, Shinagawa‐Kobayashi, Yoko, Niwa, Yusuke, Kimura, Atsushi, Sakai, Norihiro, Ko, Masayoshi, Nishina, Hiroshi, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886305/
https://www.ncbi.nlm.nih.gov/pubmed/31561285
http://dx.doi.org/10.1002/2211-5463.12734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886305/
https://www.ncbi.nlm.nih.gov/pubmed/31561285
http://dx.doi.org/10.1002/2211-5463.12734

Ejemplares similares